Business briefs, June 4
Durham-Chapel Hill home prices up from 2013
IRVINE, Calif. – Durham Chapel-Hill home prices, including distressed sales, grew by 4.1 percent year-over-year in April, according to CoreLogic.
The California-based property information, analytics and data services provider reported home sale data on Tuesday.
While the area’s home prices were up compared with April 2013, they were down from this March.
Home prices including distressed sales decreased by 0.4 percent in April from March’s numbers.
Excluding distressed sales, year-over-year prices grew by 3.7 percent in April compared with the same month in 2013. Excluding distressed sales, the CoreLogic HPI indicates home prices decreased by 1.4 percent in April 2014 compared to March 2014.
BioCryst completes stock offering
DURHAM – BioCryst Pharmaceuticals has completed its recent underwritten public offering, the company announced Tuesday.
The company said it saw gross proceeds of $115 million from the sale of 1.5 million shares of common stock at $10 a share as well as from the sale of stock through an additional option offered to the underwriters to buy additional shares.
That total doesn’t account for underwriting discounts and commissions as well as estimated offering expenses.
The company plans to use the net proceeds for development of its hereditary angioedema compound, commercialization of its flu treatment peramivir and other work.